Manufacturer record
Affy Parenterals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
36 batches manufactured by Affy Parenterals (Himachal Pradesh) were declared Not of Standard Quality between October 2023 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
36 records linked to Affy Parenterals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
36Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
36
NSQ batches since 2023
18
Products affected
Assay
Most common failure
May 2026
Latest alert
Flagged batches per year
2023 · 72024 · 12025 · 242026 · 4
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Injection | PGY25252Mfg 2025-04 · Exp 2027-03 | The sample does not conform to IP 2022 requirements w.r.t pHpH | DTL,Dalgate Srinagar kashmirState lab | May 2026 |
| Albendazole Tablets IP | PGT24427Mfg 2024-07 · Exp 2027-06 | The sample does not conform to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab | Apr 2026 |
| Albendazole Tablets IP | PGT24953Mfg 2024-11 · Exp 2027-10 | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | RDTL, ChandigarhCDSCO lab | Mar 2026 |
| Amoxycillin & Potassium Clavulanate Oral Suspension | PD24089Mfg 2024-09 · Exp 2026-08 | The sample shows absence of Clavunic acid both in Identification test and AssayAssay | DTL, Pasteur Hills,Shillong-MeghalayaState lab | Feb 2026 |
| Albendazole Tablet IP | PGT24347Mfg 2024-06 · Exp 2027-05 | The sample does not conform to claim as per IP 2022 in respect to The Test of DissolutionDissolution | RDTL, ChandigarhCDSCO lab | Dec 2025 |
| Telmisartan Tablets IP | PGT24669Mfg 2024-09 · Exp 2026-08 | DescriptionDescription | MDTL Kathua ( J&K)State lab | Sep 2025 |
| Telmisartan Tablets IP | PGT241031Mfg 2024-12 · Exp 2026-11 | Description and DissolutionDissolution | MDTL Kathua ( J&K)State lab | Sep 2025 |
| Telmisartan Tablets | PGT24720Mfg 2024-09 · Exp 2026-08 | DissolutionDissolution | DTL,Dalgate Srinagar Kashmir( J&K)State lab | Sep 2025 |
| Ondansetron Injection IP | PGY25248Mfg 2025-04 · Exp 2027-03 | pH.pH | DTL,Dalgate Srinagar Kashmir(J&K)State lab | Sep 2025 |
| Albendazole Tablets IP Legal Sample ) | PGT25229Mfg 2025-03 · Exp 2028-02 | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Albendazole Tablets IP | PGT25451Mfg 2025-06 · Exp 2028-05 | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Albendazole Tablets IP | PGT25480Mfg 2025-06 · Exp 2028-05 | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Albendazole Tablets IP | PGT25450Mfg 2025-06 · Exp 2028-05 | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Albendazole Tablets IP | PGT25229Mfg 2025-03 · Exp 2028-02 | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab | Sep 2025 |
| Levocetirizine Tablets IP | PGT241234Mfg 2025-12 · Exp 2025-11 | DescriptionDescription | Jammu and KashmirState lab | Aug 2025 |
| Telmisartan Tablets IP | PGT241031Mfg 2024-12 · Exp 2026-11 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jul 2025 |
| Ketoconazole Tablets IP 200mg | PGT241013Mfg 2024-12 · Exp 2026-11 | The sample does not conforms to IP 2022 in respect of the Assay of KetoconazoleAssay | DTL, Baddi, Himanchal PradeshState lab | Jul 2025 |
| Calcium and Vitamin D3 Tablets IP | PGT24708Mfg 2024-09 · Exp 2026-08 | The sample does not conform to the IP with respect to Assay of Vitamin D3Assay | DTL, JaipurState lab | Jul 2025 |
| Calcium and Vitamin D3 Tablets IP | PGT24702Mfg 2024-09 · Exp 2026-08 | The sample does not conform to the IP with respect to Assay Vitamin D3Assay | DTL, JaipurState lab | Jul 2025 |
| Calcium and Vitamin D3 Tablets IP | PGT24720Mfg 2024-10 · Exp 2026-09 | The sample does not conform to the IP with respect to Assay Vitamin D3Assay | DTL, JaipurState lab | Jul 2025 |
| Calcium and Vitamin D3 Tablets IP | PGT24726Mfg 2024-10 · Exp 2026-09 | The sample does not conform to the IP with respect to Assay Vitamin D3Assay | DTL, JaipurState lab | Jul 2025 |
| ALBENDAZOLE TABLETS I.P. | PGT24407Mfg 2024-07 · Exp 2027-06 | Dissolution of AlbendazoleDissolution | RDTL, ChandigarhCDSCO lab | May 2025 |
| Calcium & Vitamin D3 Tablets IP (JKMSCL, Supply) | PGT24673Mfg 2024-09 · Exp 2026-08 | The sample does not conform to IP 2022 w.r.t Disintegration test for the sample portion receivedDisintegration | CFDL Jammu (J&K)State lab | Apr 2025 |
| Cholecalciferol (Vitamin D3) 60000 IU/gm Granule Sachet | TPD24015Mfg 2024-07 · Exp 2026-06 | Assay/content of Cholecalciferol (Vitamin D3)Assay | CDL, KolkataCDSCO lab | Mar 2025 |
| Cholecalciferol (Vitamin D3) 60000 IU/gm Granule Sachet | TPD24020Mfg 2024-07 · Exp 2026-06 | Assay/content of Cholecalciferol (Vitamin D3)Assay | CDL, KolkataCDSCO lab | Mar 2025 |
| Cholecalciferol (Vitamin D3 ) 60000 IU/gm Granule Sachet | TPD24019Mfg 2024-07 · Exp 2026-06 | Assay/content of Cholecalciferol (Vitamin D3)Assay | CDL, KolkataCDSCO lab | Mar 2025 |
| Cholecalciferol (Vitamin D3 ) 60000 IU/gm Granule Sachet | TPD24018Mfg 2024-07 · Exp 2026-06 | Assay/content of Cholecalciferol (Vitamin D3)Assay | CDL, KolkataCDSCO lab | Mar 2025 |
| Calcium & Vitamin D3 Tablets IP | PGT246 72Mfg 2024-09 · Exp 2026-08 | The sample does not conform to the IP 2022 requirement with respect to uniformity of weightsUniformity of weight/content | DTL Srinagar (J&K)State lab | Feb 2025 |
| Iron Sucrose Injection USP- 5ML | PGY23118Mfg 2023-08 · Exp 2025-07 | Sample does not conform to requirement for assay for iron.Assay | King Institute ChennaiState lab | Dec 2024 |
| Unlabeled vials with Red seal purported to contains Pantoprazole 40 mg | Not applicableMfg ? · Exp ? | Misbranded with respect to labelMisbranded | CDL KolkataCDSCO lab | Nov 2023 |
| Unlabeled unpacked soft gelatin capsules purported to contain Calcitriol 0.25 mcg, Calcium 200 mg, Zinc 7.5mg | UnlabeledMfg ? · Exp ? | Assay of Calcitriol, Calcium Carbonate and Zinc Sulphate MonohydrateAssay | CDL KolkataCDSCO lab | Nov 2023 |
| Unlabeled vials with white seal purported to contains Tigecycline 50 mg | Not applicableMfg ? · Exp ? | Assay of TigecyclineAssay | RDTL ChandigarhCDSCO lab | Oct 2023 |
| Unlabeled unpacked soft gelatin capsules purported to contain Vitamin D3, 60000 IU | Not applicableMfg ? · Exp ? | Assay of Vitamin D3Assay | CDL KolkataCDSCO lab | Oct 2023 |
| Unlabeled bottles purported to contain Amoxycillin 200 mg and Clavulanic acid 28.5 mg | Not applicableMfg ? · Exp ? | Content of waterWater content | CDL KolkataCDSCO lab | Oct 2023 |
| Leucovorin Calcium Injection IP (Medivorin Injection) | LCL0322A1Mfg 2022-03 · Exp 2024-02 | Extractable volume, Particulate matter and pHParticulate matter | RDTL ChandigarhCDSCO lab | Oct 2023 |
| Cholecalciferol Soft Gelatin Capsules 60000 IU (Fexit-D3) | PSG23161Mfg 2023-07 · Exp 2025-06 | Assay of CholecalciferolAssay | CDL KolkataCDSCO lab | Oct 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.